Unisurge was founded in 1988 and reimagined in 2004, then pioneering the Custom Procedure Pack (CPT) market in the UK. The company, among others, known for brands like “Formula” (Custom Procedure Packs), “Uniform” (Surgical Drapes) and “Signature” (Surgical instruments) has established a strong reputation in the medical industry, providing high-quality products that meet the stringent demands of healthcare professionals in the hospital sector of UK, especially at the NHS. At the two sites in Newmarket (headquarters) and Castleford, more than 280 employees currently work in administration, production, logistics (including the company's own fleet) and direct sales. Unisurge is the only CPT provider in the UK with internal end-to-end processes (sterilization, production, transport). The company has been able to record growing market share in recent years resulting in a turnover of 48.5 million pounds in 2024.
The L&R Group is a leading, internationally active private company specializing in medical devices and hygiene products and services. L&R develops, manufactures, and sells products and services for wound care, including negative pressure wound therapy, compression products and systems, and OR products. With today more than 5,600 employees worldwide, more than 50 subsidiaries, and shareholdings in 28 countries, along with more than 140 selected distribution partners, L&R is present in all major markets around the globe.
The group of companies achieved a sales volume of approximately 813 million euros in 2024.
With this acquisition, effective March 31, 2025, the L&R Group secures market access to the hospital sector and surgical products in the UK. It will enhance the Group’s product portfolio and strengthen its position in the UK market and in the European OR product market. This strategic move aligns with its corporate strategy, which emphasizes growth through strategic mergers and acquisitions as one of the key drivers for future expansion.
Unisurge will continue to operate under its current name as a subsidiary of L&R with an independent brand. Current Unisurge CEO Amir Farboud will continue to lead the business, while all jobs at Unisurge will be retained. This decision underscores L&R's dedication to maintaining the strengths and culture of Unisurge while fostering collaboration and growth.
The British sales subsidiary of the group, L&R Medical UK Ltd, will not be involved in the OR business. L&R Medical UK Ltd. is located in Burton upon Trent (Staffordshire) and will continue to focus on solutions for wound care and compression therapy as it does today.
Joint Statement from L&R CEO & COO Thomas Menitz and CFO Holger Mägdefrau:
"We are thrilled to welcome Unisurge to the L&R family. This acquisition represents a significant milestone in our company strategy as it is one of the largest acquisitions in the history of the group. Having Unisurge in our Group means we enhance our capabilities and market presence in the UK. The Unisurge team have done a very good and successful job, and since we are both family businesses, we are convinced that our common path will be characterized by mutual understanding and solidarity – and of course success. Combining our strengths, we look forward to delivering exceptional value and service to our customers in the UK.”
Quote from Amir Farboud, CEO of Unisurge:
"We are very excited to join the L&R Group, a company that shares our commitment to customer focus, quality and reliability. Being part of L&R will enable us to leverage L&R's global expertise and resources while continuing to operate as an independent, well-known and trusted partner for our customers. Our employees are the backbone of our success, and we are pleased that L&R recognizes and values their contributions. Together, we will continue to provide outstanding products and services to the NHS and our further customers."
Contact:
L&R
Phone: +49 2634 99-0
Fax: +49 2634 99-6467
Email: info@de.LRmed.com